Âé¶¹¾«Ñ¡

Psychedelics as medicines? The troubled journey towards better mental health futures

In this post, Helena Da Costa, Matt Hayler and Muireann Quigley explain the relation of psychedelics to mental health.

Aston Webb building at the University Âé¶¹¾«Ñ¡

Since their emergence into western consciousness in the 1950s, integrating psychedelics into clinical, social, and legal frameworks has been a persistent challenge. For decades, sceptical perspectives resulted in regulatory frameworks that stifled research and clinical application. More recently, psychedelics have been under reconsideration for their potential to revolutionise treatments for post-traumatic stress disorder (PTSD), depression, anxiety, and a variety of addictions. Despite the optimism generated by clinical trials, however, the path to approval remains fraught with legal, regulatory, and ethical hurdles that need to be addressed if the psychedelic promissory is to be fully realised.